Research & KnowledgeEvent: September 8, 2026
Novavax presented a poster during the International C. difficile Symposium highlighting the potential of its technology platform to support the development of a multivalent C. diff vaccine candidate.
Published
Signal category
Research & Knowledge
Quote
“During this year’s International C. difficile Symposium, Raj K. will present a poster highlighting the potential of our technology platform to support the development of a multivalent C. diff vaccine candidate.”
— Novavax team
Company
Novavax
Powering innovation. Protecting health.
- Industry
- Biotechnology Research
- Location
- Gaithersburg, US
- Company size
- 937 employees
We envision a world where our technology is amplified to touch the lives of billions, sparking transformation in global health.
Founded 1987